1. Home
  2. PCRX vs QSI Comparison

PCRX vs QSI Comparison

Compare PCRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Quantum-Si Incorporated

QSI

Quantum-Si Incorporated

HOLD

Current Price

$0.94

Market Cap

273.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
QSI
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
273.7M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
QSI
Price
$23.24
$0.94
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$37.60
$1.00
AVG Volume (30 Days)
740.6K
3.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$9.77
$196.35
Revenue Next Year
$9.71
$229.03
P/E Ratio
$147.31
N/A
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$0.84
52 Week High
$27.99
$3.10

Technical Indicators

Market Signals
Indicator
PCRX
QSI
Relative Strength Index (RSI) 55.05 45.02
Support Level $23.10 $0.90
Resistance Level $23.82 $1.03
Average True Range (ATR) 1.06 0.07
MACD 0.08 0.01
Stochastic Oscillator 77.96 38.99

Price Performance

Historical Comparison
PCRX
QSI

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About QSI Quantum-Si Incorporated

Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.

Share on Social Networks: